DEMENTIA/ALZHEIMER

EIP Pharma also announced results from the REVERSE-SD study that examined neflamapimod in early stage Alzheimer disease.
The director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed the ground that has been made in treating dementia, and how nuance in diagnosis can provide a possible leg up for physicians.

SAP Partner Banner

About NeurologyLive's Dementia & Alzheimer Clinical Focus page:

NeurologyLive Dementia & Alzheimer Disease Clinical Focus page serves as a resource for clinical news, articles, videos, and newly released data pertaining to both dementia and Alzheimer disease. Coverage found here includes updates from the floor of conferences and annual meetings attended by the world’s most respected key neurology thought leaders, as well as video interviews with leading experts in these neurological disorders.

This page features breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from the new and emerging therapies being evaluated in clinical trials, and notifications of updates to clinical guidelines. The Dementia & Alzheimer Clinical Focus page provides relevant, high-quality resources for practicing neurologists, to help improve patient care.